Related Experiment Video
Updated: Dec 28, 2025

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
Published on: September 26, 2018
Memory T cells delay the progression of atherosclerosis via AMPK signaling pathway
Li-Ping Peng1, Yu Cao1, Shao-Li Zhao2
1Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha 410013, China.
Background:
Memory T cells play a key role in the development of atherosclerosis (AS). This study aimed to investigate the role of AMPK signaling pathway of spleen memory T cells in the pathogenesis of AS in high-fat diet (HFD) fed mice.
Methods:
Mice were divided into 5 groups: normal group, AS group, AS + solvent group, AS + Compound C (AMPK inhibitor) group and AS + A-769662 (AMPK agonist) group. HFD animals were intraperitoneally treated with Compound C at 20 mg/kg thrice weekly or A-769662 at 30 mg/kg once daily for 15 weeks. Then, the degree of AS was assessed, and the proportion of memory T cell was determined by flow cytometry.
Results:
AS was evident in the aorta of HFD mice. The areas of plaque formation in both AS + Compound C group and AS + A-769662 group reduced as compared to the AS group and AS + solvent group. After intervention of AMPK activity, the proportion of memory T cells in the spleen reduced as compared to the AS group and AS + solvent group; the pro proportion of memory T cells in HFD groups was markedly higher than in the normal group and this increase was more evident in the AS + Compound C than in the AS + A-769662 group.
Conclusions:
The decreased memory T cells can improve AS, which may be related to the AMPK signaling pathway. Thus, AMPK in the memory T cells may serve as a target in the prevention and treatment of AS.
Related Concept Videos
Inflammation
Atherosclerosis III: Management
Atherosclerosis I: Introduction
PI3K/mTOR/AKT Signaling Pathway
Coronary Artery Disease II: Pathophysiology
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

